Successful treatment of common variable immunodeficiency disorder-associated diarrhea with budesonide: A case report

American Journal of Gastroenterology

Volumn 102, Issue 6, 2007, Pages 1322-1325

  Elnachef, Najwa ^a   McMorris, Marc ^a   Chey, William D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LOPERAMIDE; PREDNISONE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CASE REPORT; CHRONIC DIARRHEA; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; RECURRENT DISEASE; STEATORRHEA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; BUDESONIDE; CHRONIC DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; DIARRHEA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED;

EID: 34249113461     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01141.x     Document Type: Article

References (14)

1. DiRenzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: A review. Clin Exp Med 2004 3 : 211 7.
2. Sneller M. Common variable immunodeficiency. Am J Med Sci 2001 321 : 42 8.
3. Rosen F, Cooper M, Wedgwood R. The primary immunodeficiencies. N Engl J Med 1995 333 : 431 40.
4. Luzi G, Zullo A, Iebba F, et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol 2003 98 : 118 21.
5. Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep 2004 6 : 377 83.
6. Lai Ping So A, Mayer L. Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 1997 8 : 22 32.
7. Fedorak RN, Bistritz L. Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv Drug Deliv Rev 2005 57 : 303 16.
8. Edsbacker S, Andersson T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin Pharmacokinet 2004 43 : 803 21.
9. Cortot A, Colombel JF, Rutgeerts P, et al. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut 2001 48 : 186 90.
10. Sandborn WJ, Lofberg R, Feagan BG, et al. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol 2005 100 : 1780 7.
11. Aukrut P, Lien E, Kristoffersen AK, et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency: Possible immunologic and clinical consequences. Blood 1996 87 : 674 81.
12. Rubio-Tapia A, Hernández-Calleros A, Trinidad-Hernández A, et al. Clinical characteristics of a group of adults with nodular lymphoid hyperplasia: A single center experience. World J Gastroenterol 2006 12 : 1945 8.
13. Kohler PF, Cook RD, Brown WR, et al. Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: Different lymphocyte populations with a similar response to prednisone therapy. J Allergy Clin Immunol 1982 70 : 299 305.
14. Pardi DS, Ramnath VR, Loftus EV, et al. Lymphocytic colitis: Clinical features, treatment and outcomes. Am J Gastroenterology 2002 97 : 2829 33.